Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01877096 | Motivational Interviewing for Colonoscopy | completed | N/A | 57 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Nov 4, 2015 | clinicaltrials |
| NCT00207155 | An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer | completed | Phase 1 | 110 | Eli Lilly and CompanyINDUSTRY | 3 | Oct 28, 2015 | clinicaltrials |
| NCT00729677 |
| Delayed Nausea and Vomiting in Patients With Colorectal Cancer Receiving Oxaliplatin |
| completed |
| — |
| 64 |
| Beth Israel Medical CenterOTHER |
| 1 |
| Oct 26, 2015 |
| clinicaltrials |
| NCT01516489 | Improving Fecal Occult Blood Test Completion Rates Among Veterans | completed | Phase 1 / Phase 2 | 1,549 | Corporal Michael J. Crescenz VA Medical CenterFED | 1 | Oct 26, 2015 | clinicaltrials |
| NCT00085163 | Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon | completed | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Oct 20, 2015 | clinicaltrials |
| NCT02266056 | The Benefits of Deep Neuromuscular Block and Sugammadex in Laparoscopic Colorectal Surgery | completed | N/A | 72 | Yonsei UniversityOTHER | 1 | Oct 19, 2015 | clinicaltrials |
| NCT01697449 | An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (RELEVANT) | completed | — | 191 | Hoffmann-La RocheINDUSTRY | 1 | Oct 16, 2015 | clinicaltrials |
| NCT00103142 | Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer | completed | Phase 2 | 74 | Michael Morse, MDOTHER | 1 | Oct 14, 2015 | clinicaltrials |
| NCT00402961 | Trial of Acupuncture for Reduction of Post-Colectomy Ileus | completed | Phase 2 | 90 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 12, 2015 | clinicaltrials |
| NCT00851045 | Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer | completed | Phase 2 | 17 | Bristol-Myers SquibbINDUSTRY | 3 | Oct 12, 2015 | clinicaltrials |
| NCT00684801 | Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers | completed | — | 605 | Case Comprehensive Cancer CenterOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT01164215 | Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy | completed | Phase 1 | 76 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT01703910 | Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic | completed | Phase 2 | 29 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT02386618 | Endoscopic Treatment for Local Residual Neoplasia | completed | N/A | 25 | Vitkovice HospitalOTHER | 1 | Oct 6, 2015 | clinicaltrials |
| NCT02226107 | Latino Peers as Patient Navigators for Colon Cancer Screening | completed | N/A | 85 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Oct 1, 2015 | clinicaltrials |
| NCT02367001 | Randomized Trial Evaluating the Effectiveness of the General Practitioner Involvement in Cancer Screening Invitations(GPs) | completed | N/A | 53,978 | University Hospital, ToursOTHER | 1 | Oct 1, 2015 | clinicaltrials |
| NCT00397384 | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT00905086 | Psychosocial Adjustment After Radiation Therapy in Patients With Cancer | completed | — | 80 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 30, 2015 | clinicaltrials |
| NCT00972751 | S9304A Study of Protein Expression in Tumor Tissue Samples From Patients With Stage II or Stage III Rectal Cancer Enrolled in Clinical Trial SWOG-9304 | completed | — | 220 | SWOG Cancer Research NetworkNETWORK | 0 | Sep 30, 2015 | clinicaltrials |
| NCT01356264 | Multimodal Prehabilitation for Colorectal Surgery | completed | Phase 2 | 89 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Sep 29, 2015 | clinicaltrials |
| NCT00689624 | Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer | completed | Phase 2 | 30 | University Hospital of CreteOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT02558881 | Colon Capsule Versus Virtual Colonoscopy for Colorectal Cancer Screening(COCAGI) | completed | — | 664 | Hospices Civils de LyonOTHER | 1 | Sep 24, 2015 | clinicaltrials |
| NCT01216930 | Molecular Screening for Lynch Syndrome in Southern Denmark | completed | — | 2,000 | Vejle HospitalOTHER | 1 | Sep 14, 2015 | clinicaltrials |
| NCT02548403 | Effect of Simethicone on Bowel Preparation for Colonoscopy | completed | Phase 3 | 260 | Korea University Anam HospitalOTHER | 1 | Sep 14, 2015 | clinicaltrials |
| NCT02545725 | Quality of Life in Colorectal (ex-)Cancer Patients, Based on the Belgian Cancer Registry.(QOLColorect) | completed | — | 1,220 | Elizabeth Van EyckenOTHER | 1 | Sep 10, 2015 | clinicaltrials |
| NCT02543762 | Usefulness of Chromoendoscopy for the Early Detection of Colorectal Cancer Associated With Inflammatory Bowel Disease(CE) | completed | — | 350 | Hospital Clinic of BarcelonaOTHER | 1 | Sep 7, 2015 | clinicaltrials |
| NCT01323166 | Quality of Life After Abdominoperineal Resection for Rectal Cancer, Comparing Two Surgical Techniques(APR) | completed | — | 75 | Sahlgrenska University HospitalOTHER | 1 | Sep 4, 2015 | clinicaltrials |
| NCT00502671 | A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer. | completed | Phase 4 | 228 | Hoffmann-La RocheINDUSTRY | 1 | Sep 3, 2015 | clinicaltrials |
| NCT01483443 | Oophorectomy Followed by Chemotherapy Versus Chemotherapy Alone in Colorectal Cancer Patients | completed | Phase 3 | 140 | Gachon University Gil Medical CenterOTHER | 1 | Sep 1, 2015 | clinicaltrials |
| NCT00577031 | OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum. | completed | Phase 4 | 205 | Hoffmann-La RocheINDUSTRY | 1 | Aug 18, 2015 | clinicaltrials |
| NCT00188305 | A Randomized Trial of Cancer Risk and Health Education in Relatives of Colorectal Cancer Patients | completed | Phase 3 | 252 | University Health Network, TorontoOTHER | 1 | Aug 17, 2015 | clinicaltrials |
| NCT01227707 | A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. | completed | Phase 2 | 43 | Hoffmann-La RocheINDUSTRY | 1 | Aug 17, 2015 | clinicaltrials |
| NCT00126256 | Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer | completed | Phase 3 | 570 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02518373 | Effect of G17DT in Patients With Stage II/III Colorectal Cancer(CC5) | completed | Phase 2 | 22 | Cancer Advances Inc.INDUSTRY | 0 | Aug 7, 2015 | clinicaltrials |
| NCT02054923 | The Effect of Routine Video-recording on Colonoscopy Quality Indicators. | completed | N/A | 5,200 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Aug 5, 2015 | clinicaltrials |
| NCT01580540 | Head to Head Study Epi proColon and FIT | completed | — | 336 | Epigenomics, IncINDUSTRY | 2 | Aug 4, 2015 | clinicaltrials |
| NCT00700102 | A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer. | completed | Phase 3 | 820 | Hoffmann-La RocheINDUSTRY | 15 | Jul 30, 2015 | clinicaltrials |
| NCT00100841 | Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer | completed | Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jul 27, 2015 | clinicaltrials |
| NCT01161316 | Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours(MACRO-2) | completed | Phase 2 | 194 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Jul 27, 2015 | clinicaltrials |
| NCT00052507 | Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer | completed | Phase 2 | — | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT01030042 | Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic Patients(COMETS) | completed | Phase 3 | 110 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Jul 15, 2015 | clinicaltrials |
| NCT01853813 | First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colorectal Cancer(CENTRAL) | completed | Phase 2 | 85 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Jul 15, 2015 | clinicaltrials |
| NCT00890305 | Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone | completed | Phase 2 | 171 | Medivation, Inc.INDUSTRY | 6 | Jul 8, 2015 | clinicaltrials |
| NCT01478594 | A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy | completed | Phase 2 | 265 | AVEO Pharmaceuticals, Inc.INDUSTRY | 12 | Jul 8, 2015 | clinicaltrials |
| NCT02251782 | Adherence to Minimally Invasive Testing(ADMIT) | completed | — | 490 | Epigenomics, IncINDUSTRY | 1 | Jun 30, 2015 | clinicaltrials |
| NCT01405430 | Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab(AVECC) | completed | N/A | 63 | Centre Leon BerardOTHER | 1 | Jun 29, 2015 | clinicaltrials |
| NCT01482741 | Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging | completed | — | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2015 | clinicaltrials |
| NCT01103323 | Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy | completed | Phase 3 | 760 | BayerINDUSTRY | 19 | Jun 24, 2015 | clinicaltrials |
| NCT01461148 | Vaccination Against MSI Colorectal Cancer | completed | Phase 1 / Phase 2 | 22 | Oryx GmbH & Co. KGINDUSTRY | 1 | Jun 23, 2015 | clinicaltrials |
Data updated 24 days agoSource updated Nov 4, 2015source: clinicaltrials